Shared Genes Between Systemic Sclerosis and Lung Cancer
Author Information
Author(s): Pan Pengfei, Liu Xin, Wang Yun, Wang Huixuan, Xu Cheng, Lu Junhui
Primary Institution: The Affiliated Huai’an Hospital of Xuzhou Medical University
Hypothesis
This study aims to identify genes shared by systemic sclerosis (SSc) and lung cancer.
Conclusion
PRKG2 is identified as a core shared gene between systemic sclerosis and lung cancer, influencing cell proliferation and invasion.
Supporting Evidence
- PRKG2 was overexpressed in lung cancer cells to study its effects.
- Seven shared genes were identified between SSc and lung cancer.
- PRKG2 expression levels were lower in lung cancer patients compared to normal individuals.
- High PRKG2 expression was associated with better disease-free survival in lung cancer patients.
Takeaway
The study found that a gene called PRKG2 is important for both systemic sclerosis and lung cancer, and it helps control how cancer cells grow and spread.
Methodology
The study used bioinformatics to analyze gene expression data from public databases and identified differentially expressed genes (DEGs) related to both diseases.
Potential Biases
Potential selection bias may be present due to the datasets used.
Limitations
The study did not evaluate the effects of PRKG2 in SSc animal models and lacked demographic data for subgroup analyses.
Participant Demographics
The study analyzed data from 18 SSc patients and 15 healthy controls.
Statistical Information
P-Value
0.028
Statistical Significance
p=0.028
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website